comparemela.com

Latest Breaking News On - Takeda vaccines inc - Page 1 : comparemela.com

HilleVax : Corporate Presentation - MarketScreener

CORPORATE PRESENTATION MAY 2024 Disclaimer We caution you that this presentation contains forward-looking.

United statesExchange commissionHillevax incTakeda vaccines incTakeda vaccinesPrivate securities litigation reform act

HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer

HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAditya kohliShane maltbieRob hershbergHillevax incKanghua biological products co ltdTakeda vaccines incExchange commissionSean mcloughlinChief operatingChief operating officerChief business officerGlobal vaccine commercialization leadNew product strategy leadVaccines business unitChief executive officer

HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China

BOSTON and CHENGDU, China, Jan. 08, 2024 (GLOBE NEWSWIRE) HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused o.

United statesShane maltbieRob hershbergWennian wuWang zhentaoPostdoctoral innovation practiceNational medical products administrationGroup ltdChengdu kanghua biological products co ltdTakeda vaccines incHillevax incMinistry of scienceMinistry of personnelExchange commissionInvestigational new drugChief executive officer

HilleVax to Present at the 42nd Annual J P Morgan Healthcare Conference

04.01.2024 - BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) - HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it will present at the 42nd Annual J.P. Morgan .

United statesShane maltbieTakeda vaccines incExchange commissionTakeda vaccinesPrivate securitiesLitigation reform actHillevax chartIllevax kursIllevax aktie

HilleVax to Present at the 42nd Annual J P Morgan Healthcare Conference - HilleVax (NASDAQ:HLVX)

BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that it will present at the

United statesSan franciscoShane maltbieTakeda vaccines incHillevax incExchange commissionHealthcare conferenceTakeda vaccinesPrivate securities litigation reform act

vimarsana © 2020. All Rights Reserved.